Drawing for DIGERIL

USPTO serial 88060155

DIGERIL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
โ€”
Examiner
PILARO, MARK F
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DIGERIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rodrigo Bermeo Andrade

Rodrigo Bermeo Andrade BERMEO & BERMEO LAW FIRM135 WESTON RD199WESTON, FL 33326

Goods and services

ClassDescriptionStatusFirst use
005Digestives for pharmaceutical purposes; Gastro-intestinal treatment preparations; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseasesACTIVEโ€”

Related trademarks

CopyMark links this record to cited ยง2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 4, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 4, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 15, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDโ€”
Jan 14, 2022EX5GSOU EXTENSION 5 GRANTEDโ€”
Jan 14, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGALโ€”
Nov 20, 2021NREVNOTICE OF REVIVAL - E-MAILEDโ€”
Nov 20, 2021DOCKASSIGNED TO EXAMINERโ€”
Nov 19, 2021TPEXSOU EXTENSION RECEIVED WITH TEAS PETITIONโ€”
Nov 19, 2021PETGPETITION TO REVIVE-GRANTEDโ€”
Nov 19, 2021PROATEAS PETITION TO REVIVE RECEIVEDโ€”
Sep 27, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 27, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 26, 2021EXT5SOU EXTENSION 5 FILEDโ€”
Feb 23, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDโ€”
Feb 19, 2021EX4GSOU EXTENSION 4 GRANTEDโ€”
Feb 19, 2021EXT4SOU EXTENSION 4 FILEDโ€”
Feb 19, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 20, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDโ€”
Aug 18, 2020EX3GSOU EXTENSION 3 GRANTEDโ€”
Aug 18, 2020EXT3SOU EXTENSION 3 FILEDโ€”
Aug 18, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 14, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDโ€”
Feb 12, 2020EX2GSOU EXTENSION 2 GRANTEDโ€”
Feb 12, 2020EXT2SOU EXTENSION 2 FILEDโ€”
Feb 12, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 28, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDโ€”
Aug 26, 2019EX1GSOU EXTENSION 1 GRANTEDโ€”
Aug 26, 2019EXT1SOU EXTENSION 1 FILEDโ€”
Aug 26, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 26, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline โ€” usually six months from the notice date.
Jan 1, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDโ€”
Jan 1, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 12, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDโ€”
Nov 28, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTERโ€”
Nov 16, 2018DOCKASSIGNED TO EXAMINERโ€”
Aug 7, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTEREDโ€”
Aug 3, 2018NWAPNEW APPLICATION ENTEREDโ€”

Frequently asked questions

Related guidance